Elevated homocysteine and carotid plaque area and densitometry in the northern Manhattan study

Stroke

Volumn 44, Issue 2, 2013, Pages 457-461

  Alsulaimani, Sara ^a,b   Gardener, Hannah ^b   Elkind, Mitchell S V ^c   Cheung, Ken ^b,c   Sacco, Ralph L ^b   Rundek, Tatjana ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

atherosclerosis; carotid arteries; echodense plaque; echolucent plaque; gray scale median; homocysteine; plaque area; ultrasonography

Indexed keywords

HOMOCYSTEINE;

AFRICAN AMERICAN; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY DISEASE; CAROTID ATHEROSCLEROSIS; CAROTID PLAQUE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYANOCOBALAMIN DEFICIENCY; DENSITOMETRY; EUROPEAN AMERICAN; FEMALE; GRAY SCALE MEDIAN; HISPANIC; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; RISK FACTOR; TOTAL PLAQUE AREA;

AGED; BIOLOGICAL MARKERS; CAROTID STENOSIS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENSITOMETRY; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES;

EID: 84872951685     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.676155     Document Type: Article

References (47)

1. Dietrich M, Jacques PF, Polak JF, Keyes MJ, Pencina MJ, Evans JC, et al. Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study. J Stroke Cerebrovasc Dis. 2011;20:155-161.
2. McQullailn MB, Beibly JP, Nidrof M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolatereductase is an indepenedent risk determinant of wall thickening: The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation.1999;99:2383-2388.
3. Adachi H, Hirai Y, Fujiura Y, Matsuoka H, Satoh A, Imaizumi T. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke. 2002;33:2177-2181.
4. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation. 1993;87:1107-1113.
5. Nukata M, Taguchi A, Kitagawa K, Kinoshita N, Sasaki M, Watanabe M, et al. Association of Plasma Homocysteine Concentration With Atherosclerotic Carotid Plaques and Lacunar Infarction. Stroke.2002;33:1493-1496.
6. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest. 1976;57:1079-1082.
7. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-1057.
8. Collaboration HLT. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J ClinNutr. 2005; 82:806-12.
9. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost. 1998;80:874-877.
10. Spence JD, Malinow MR, Barnett PA, Marian AJ, Freeman D, Hegele RA. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke. 1999;30:969-973.
11. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics - 2010 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2010; 121:e1-e170.
12. Rundek T, Sacco RL. Risk factor management to prevent first stroke. Neurol Clin. 2008;26:1007-45, ix.
13. Roman Sztajzel R. Ultrasonographic assessment of the morphological characteristics of the carotid plaque. Swiss Med Wkly 2005;135:635-643.
14. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33:2916-2922.
15. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke. 2004;35:2263-2269.
16. Spence JD, Blake C, Landry A, Fenster A. Measurement of carotid plaque and effect of vitamin therapy for total homocysteine. Clin Chem Lab Med. 2003;41:1498-1504.
17. Robertson J, Iemolo F, Stabler SP, Allen RH, Spence JD. Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products. CMAJ. 2005;172:1569-1573.
18. Della-Morte D, Moussa I, Elkind MS, Sacco RL, Rundek T. The short-term effect of atorvastatin on carotid plaque morphology assessed by computerassisted gray-scale densitometry: a pilot study. Neurol Res. 2011;33:991-994.
19. Spence JD, Stampfer MJ. Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses. JAMA. 2011;306:2610-2611.
20. Office of Management and Budget. Race and ethnic standards for federal statistics and administrative reporting. Federal Register. May 4, 1978; 43: 19269. Directive No. 15
21. Elkind MS, Cheng J, Boden-Albala B, Paik MC, Sacco RL; Northern Manhattan Stroke Study. Elevated white blood cell count and carotid plaque thickness: the Northern Nanhattan Stroke Study. Stroke. 2001;32:842-849.
22. Gardener H, Della Morte D, Elkind MS, Sacco RL, Rundek T. Lipids and carotid plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovasc Disord. 2009;9:55.
23. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC, Kranwinkel G, et al. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke. 2007;38:3121-3126.
24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
25. Hølleland G, Schneede J, Ueland PM, Lund PK, Refsum H, Sandberg S. Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem. 1999;45:189-198.
26. Ducros V, Schmitt D, Pernod G, Faure H, Polack B, Favier A. Gas chromatographic- mass spectrometric determination of total homocysteine in human plasma by stable isotope dilution: method and clinical applications. J Chromatogr B Biomed Sci Appl. 1999;729:333-339.
27. Carrelli AL, Walker MD, Lowe H, McMahon DJ, Rundek T, Sacco RL, et al. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke. 2011;42:2240-2245.
28. Kuo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, et al. Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke. 2012;43:1755-1760.
29. Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC, et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke. 1999;30:1751-1758.
30. Endarterectomy for asymptomatic carotid artery stenosis: Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273:1421-1428.
31. Biasi GM, Froio A, Diethrich EB, Deleo G, Galimberti S, Mingazzini P, et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation. 2004;110:756-762.
32. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation. 2003;107:2072-2075.
33. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.
34. Spence JD, Tamayo A, Lownie SP, Ng WP, Ferguson GG. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke. 2005;36:2373-2378.
35. Madani A, Beletsky V, Tamayo A, Munoz C, Spence JD. High-risk asymptomatic carotid stenosis: ulceration on 3D ultrasound vs TCD microemboli. Neurology. 2011;77:744-750.
36. VITATOPS Study Trial Group. B vitamins in patients with recent transient ischemic attack or stroke in the Vitamins To Prevent Stroke (VITATOPS) trial: a randomized, double blind, parallel, placebo-controlled trial. Lancet Neurol. 2010; 9:855-865.
37. Held C, Sumner G, Sheridan P, McQueen M, Smith S, Dagenais G, et al. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART). Vasc Med. 2008;13:245-253.
38. Jones BG, Rose FA, Tudball N. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis. 1994;105:165-170.
39. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997;272:17012-17017.
40. Moat SJ, Bonham JR, Cragg RA, Powers HJ. Elevated plasma homocysteine elicits an increase in antioxidant enzyme activity. Free Radic Res. 2000;32:171-179.
41. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation. 1999;99:1156-1160.
42. Chambers JC, Obeid OA, Kooner JS. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb Vasc Biol. 1999;19:2922-2927.
43. Selhub J, Jacques PF, Bostom AG, Wilson PW, Rosenberg IH. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev. 2000;28:117-145.
44. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
45. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr. 1992;12: 279-298.
46. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332: 286-291.
47. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999;99:178-182.